Journals / Ege Tıp Dergisi / 2021 / Cilt: 60 - Sayı: 2

Molecular structure of coronaviruses and stem cell use in treatment

Koronavirüslerin moleküler yapısı ve tedavide kök hücre kullanımı

Pages
172–180
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review will examine the general epidemiology, genomic nature of COVID-19 and the importance of stem cell treatments for COVID-19.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronaviruses were first discovered in the 1930s.
📊
Key Findings & Data:The COVID-19 pandemic that emerged after the SARS and MERS outbreaks caused a lot of infections and deaths in a short time.
💡
Conclusion & Impact:This review will examine the general epidemiology, genomic nature of COVID-19 and the importance of stem cell treatments for COVID-19.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Coronaviruses were first discovered in the 1930s. The COVID-19 pandemic that emerged after the SARS and MERS outbreaks caused a lot of infections and deaths in a short time. Coronaviruses are viruses with the largest RNA genome. It has a crown appearance under the microscope due to the glycoproteins it contains. Although there are no specific symptoms of COVID-19 infection, fever, cough, sputum, myalgia and headache are the most prominent symptoms. The most widely used method in its diagnosis is the PCR test. One of the treatments tried in COVID-19 infection, for which there is no standard treatment yet, is stem cell-based therapies. This review will examine the general epidemiology, genomic nature of COVID-19 and the importance of stem cell treatments for COVID-19.

Özet

Koronavirüsler ilk olarak 1930'larda keşfedilmiştir. SARS ve MERS salgınlarından sonra ortaya çıkan COVID-19 pandemisi kısa sürede çok fazla enfeksiyon ve ölüme neden oldu. Koronavirüsler en büyük RNA genomuna sahip virüslerdir. İçerdiği glikoproteinlerden kaynaklı mikroskop altında taç görünümüne sahiptir. COVID-19 enfeksiyonunun spesifik semptomları olmamasına rağmen ateş, öksürük, balgam, miyalji ve baş ağrısı en belirgin semptomlarıdır. Teşhisinde en yaygın kullanılan yöntem PCR testidir. Henüz standart bir tedavisi bulunmayan COVID-19 enfeksiyonunda denenen tedavilerden biri de kök hücre tabanlı tedavilerdir. Bu derlemede COVID-19'un genel epidemiyolojisi, genomik yapısı ve COVID-19 için kök hücre tedavilerinin önemi irdelenecektir.

🔖

Cite This Article

SOFU, M., TOMRUK, C., BAŞAROĞLU, H. K., UYANIKGİL, E. Ö. Ç., UYANIKGİL, Y. (2022). Molecular structure of coronaviruses and stem cell use in treatment. Ege Tıp Dergisi, Cilt: 60 - Sayı: 2, 172–180. https://ajindex.com/articles/496114

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Nickbakhsh S, Mair C, Matthews L, Reeve R, Johnson PCD, Thorburn F, et al. Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc Natl Acad Sci U S A. 2019; 116 (52): 27142–50
  2. Tang D, Comish P, Kang R. The hallmarks of COVID-19 disease. PLoS Pathog. 2020; 16 (5): 1–24
  3. Rodriguez-Morales AJ, Bonilla-Aldana DK, Balbin-Ramon GJ, Rabaan AA, Sah R, Paniz-Mondolfi A, et al. History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel coronavirus epidemic. Infez Med. 2020; 28 (1): 3–5
  4. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020; 92 (4): 401–2
  5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506
  6. Johnson M. Wuhan 2019 Novel Coronavirus - 2019-nCoV. Mater Methods. 2020; 10 (JANUARY): 1–5
  7. Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. 2020; 12 (2): 1–8
  8. Deng S-Q, Peng H-J. Clinical Medicine Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China. J Clin Med. 2020 Feb; 9 (2): 575.; Feb; 9 (2): 575
  9. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol 2016 Jun; 24 (6): 490-502
  10. Domingo E, Perales C. Viral quasispecies. PLoS Genet. 2019; 15 (10): 1-20
  11. Zhou P, Yang X Lou, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579 (7798): 270–3
  12. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382 (8): 727–33
  13. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020; 92: 92
  14. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. www.thelancet.com. 2020; 395: 565
  15. Glowacka I, Bertram S, Muller MA, Allen P, Soilleux E, Pfefferle S, et al. Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response. J Virol. 2011 May; 85 (9): 4122–34
  16. Hu B, Ge X, Wan